Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (6): 5-9.doi: 10.6040/j.issn.1671-7554.0.2021.0467

Previous Articles     Next Articles

Osteoporosis in men: a chronically overlooked problem

CHENG Xiaoguang1, LU Yanhui2   

  1. 1.Department of Radiology, Beijing Jishuitan Hospital, Beijing 100035, China;
    2. Department of Endocrinology, Second Medical Center of PLA General Hospital, Beijing 100853, China
  • Published:2021-06-10

RichHTML

88

PDF (PC)

376

Abstract: Osteoporosis is a systemic bone disease. The loss of bone mass and the destruction of bone microstructure increase bone fragility and ultimately lead to an increased risk of fracture. According to etiology, primary osteoporosis can be divided into postmenopausal osteoporosis(PMO)and senile osteoporosis(SO). Osteoporosis in men is mainly SO, so the onset of osteoporosis in men is later than that in women. Due to the current dependence on dual X-ray absorptiometry(DXA)in the diagnosis of osteoporosis and the survey results of DXA, the prevalence of osteoporosis in men is considered low. In addition, there are few indications of drugs for the treatment of osteoporosis in men, resulting in the overlook of the prevention and treatment of osteoporosis in men. Therefore, it is necessary to increase the application of various testing methods, including radiology, DXA and QCT in the diagnosis of osteoporosis, as well as strengthen the awareness of osteoporosis in men and its intervention.

Key words: Osteoporosis, Male, Dual X-ray absorptiometry, Quantitative computed tomography, Anti-osteoporosis therapy

CLC Number: 

  • R574
[1] Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis[J]. J Bone Miner Res, 1994, 9(8): 1137-1141.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-414.
[3] Zeng Q, Li N, Wang Q, et al. The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey[J]. J Bone Miner Res, 2019, 34(10): 1789-1797.
[4] 程晓光,董剩勇,王亮,等.应用双能X线骨密度仪调查中国人群骨密度水平和骨质疏松症患病率[J].中华健康管理学杂志, 2019, 13(1): 51-58.
[5] 中华医学会骨质疏松和骨矿盐疾病分会.男性骨质疏松症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志, 2020, 13(5): 381-395.
[6] Berger C, Goltzman D, Langsetmo L, et al. Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis [J]. J Bone Miner Res, 2010, 25(9): 1948-1957.
[7] Si L, Winzenberg TM, Jiang Q, et al. Projection of osteoporosis-related fractures and costs in China: 2010-2050[J]. Osteoporos Int, 2015, 26(7): 1929-1937.
[8] Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures[J]. BMJ, 1993, 307(6914): 1248-1250.
[9] 中华医学会放射学分会骨关节学组,中国医师协会放射医师分会肌骨学组,中华医学会骨科学分会骨质疏松学组,等.骨质疏松的影像学与骨密度诊断专家共识[J].中华放射学杂志, 2020, 54(8): 745-752.
[10] Gao C, Xu Y, Li L, et al. Prevalence of osteoporotic vertebral fracture among community-dwelling elderly in Shanghai[J]. Chin Med J(Engl), 2019, 132(14): 1749-1751.
[11] Wáng YXJ, Che-Nordin N, Deng M, et al. Osteoporotic vertebral deformity with endplate/cortex fracture is associated with higher further vertebral fracture risk: the Ms. OS(Hong Kong)study results[J]. Osteoporos Int, 2019, 30(4): 897-905.
[12] Wang L, Ran L, Zha X, et al. Adjustment of DXA BMD measurements for anthropometric factors and its impact on the diagnosis of osteoporosis[J]. Arch Osteoporos, 2020,15(1): 155. doi: 10.1007/s11657-020-00833-1.
[13] Xu XM, Li N, Li K, et al. Discordance in diagnosis of osteoporosis by quantitative computed tomography and dual-energy X-ray absorptiometry in Chinese elderly men[J]. J Orthop Translat, 2018, 18: 59-64. doi: 10.1016/j.jot.2018.11.003.
[14] Cheng X, Zhao K, Zha X, et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a nationwide, multicenter study[J]. J Bone Miner Res, 2021, 36(3): 427-435.
[15] Schousboe JT, Ensrud KE. Opportunistic osteoporosis screening using low-Dose computed tomography(LDCT): promising strategy, but challenges remain[J]. J Bone Miner Res, 2021, 36(3): 425-426.
[16] The Lancet Diabetes Endocrinology. Osteoporosis: overlooked in men for too long[J]. Lancet Diabetes Endocrinol, 2021, 9(1):1. doi:10.1016/S2213-8587(20)30408-3.
[17] Madeo B, Zirilli L, Caffagni G, et al. The osteoporotic male: overlooked and undermanaged? [J]. Clin Interv Aging, 2007, 2(3): 305-312.
[18] Porcelli T, Maffezzoni F, Pezzaioli LC, et al. Male osteoporosis: diagnosis and management-should the treatment and the target be the same as for female osteoporosis? [J]. Eur J Endocrinol, 2020, 183(3): R75-R93.
[19] Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community[J]. Cochrane Database Syst Rev, 2012, 12(9): CD007146. doi:10.1002/14651858. CD007146.pub3.
[20] Kukuljan S, Nowson CA, Sanders KM, et al. Independent and combined effects of calcium vitamin D3 and exercise on bone structure and strength in older men: an 18-month factorial design randomized controlled trial[J]. J Clin Endocrinol Metab, 2011, 96(4): 955-963.
[21] Allison SJ, Folland JP, Rennie WJ, et al. High impact exercise increased femoral neck bone mineral density in older men: a randomised unilateral intervention[J]. Bone, 2013, 53(2): 321-328.
[22] Boonen S, Reginster JY, Kaufman JM, et al. Fracture risk and zoledronic acid therapy in men with osteoporosis[J]. N Engl J Med, 2012, 367(18): 1714-1723.
[23] Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men[J]. N Engl J Med, 2000, 343(9): 604-610.
[24] Ringe JD, Dorst A, Faber H, et al. Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study[J]. Rheumatol Int, 2004, 24(2): 110-113.
[25] Boonen S, Orwoll ES, Wenderoth D, et al. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study[J]. J Bone Miner Res, 2009, 24(4): 719-725.
[26] Ringe JD, Farahmand P, Faber H, et al. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study[J]. Rheumatol Int, 2009, 29(3): 311-315.
[27] Orwoll E, Teglbjærg CS, Langdahl BL, et al. A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density[J]. J Clin Endocrinol Metab, 2012, 97(9): 3161-3169.
[28] Langdahl BL, Teglbjærg CS, Ho PR, et al. A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial[J]. J Clin Endocrinol Metab, 2015, 100(4): 1335-1342.
[29] Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone(1-34)] therapy on bone density in men with osteoporosis[J]. J Bone Miner Res, 2003, 18(1): 9-17.
[30] Kaufman JM, Orwoll E, Goemaere S, et al. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy[J]. Osteoporos Int, 2005, 16(5): 510-516.
[1] WANG Xuemei, YANG Hao, SONG Yang, CHENG Shichao, ZHANG Tingting, WANG Yanchun. Causal association of antidiabetic drugs with female malignant tumours: a two-sample Mendelian randomisation study [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 67-77.
[2] JIA Zhencun, WU Chenrui, ZHAO Delong, ZHU Kejia, DING Sentai. Efficacy and safety of Babaodan Capsule in combination with mirabegron for the treatment of overactive bladder in women [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 72-79.
[3] ZHU Chao, SUN Chao, LIU Xuchang, XIA Dawei, MA Chuncheng, FENG Rongjie. Application of 3D-printed titanium interbody fusion cage in 37 cases of single level lumbar surgery [J]. Journal of Shandong University (Health Sciences), 2023, 61(3): 134-140.
[4] WU Wenjing, SUN Yuan, WANG Guangyu, LYU Xiaoqing, YAN Chuanzhu, LIN Pengfei. Molecular genetic mechanism of Duchenne muscular dystrophy in a female case [J]. Journal of Shandong University (Health Sciences), 2023, 61(10): 95-100.
[5] CHEN Shihong, JIANG Dongqing, ZHUANG Xianghua, LI Xiaobo, PAN Zhe, SUN Aili, LOU Nengjun, WANG Dianhui, DU Jiaojiao, SONG Yuwen. Primary biliary cholangitis with bone pain as the main manifestation: a case report [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 98-102.
[6] LYU Li, JIANG Lu, CHEN Shihong, ZHUANG Xianghua, SONG Yuwen, WANG Dianhui, AN Wenjuan, LI Qian, PAN Zhe. Related factors of osteoporosis in 210 postmenopausal women with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 19-25.
[7] CHEN Shihong. Progress in glucocorticoid-induced osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 33-37.
[8] LUO Xianghang, ZHOU Ruoyu. Advances on the etiology and pathogenesis of osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 10-14.
[9] LI Minqi, DU Juan, YANG Panpan, KOU Yuying, LIU Shanshan. Research progress of oxidative stress regulating osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 16-24.
[10] DU Jiaojiao, ZHUANG Xianghua, CHEN Shihong, WANG Xuemeng, JIANG Dongqing, WU Fei, HAN Xiaolin, HUA Mengyu, SONG Yuwen. Changes of serum IL-31 and IL-33 levels in postmenopausal patients with osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 45-50.
[11] LIU Ping, SONG Yuwen, WANG Ping, TIAN Guangwei, ZHENG Fengjie, LYU Li, DU Jiaojiao, ZHANG Jing, ZHUANG Xianghua, CHEN Shihong. Correlation between vitamin D deficiency and depression in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 51-56.
[12] ZHU Xuli, ZHOU Liang, WANG Yue, SUN Qingyun, CAO Mingya, DU Yuanjie, CAO Jinfeng, ZHAO Zhiming, HAO Guimin. Correlation analysis of freezing methods with different sperm sources and pregnancy outcomes [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 86-93.
[13] XING Xiaoping. Diagnosis and management of primary osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 1-4.
[14] XU Xiaoming, ZENG Qi, CAO Jun, CHEN Xiaorong, LYU Zhen, WANG Wo, AI Ming, KONG Yiting, KUANG Li. Associations between self-harm behavior and psychosocial-polymorphism in female freshmen [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 84-92.
[15] ZHAO Lihong, ZHAO Shuping, NIE Shenggang, SUN Jing, JIANG Tongfeng. Distribution and antimicrobial resistance of multiple pathogens in 507 males with genital tract infections [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 55-58.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd